Virginia Tech Center for Drug Discovery

Chemistry’s Michael Schulz awarded National Science Foundation CAREER award The award, which begins in May, comes on the heels of Schulz receiving a U.S. Department of Energy Early Career Research Program award last year.

Developing synthetic polymers to study neurological diseases Whether he's working with undergraduates in their capstone lab or with graduate students in the Figg Research Group, Assistant Professor Adrian Figg is driven by a desire to develop polymers to study neurological diseases, such as Parkinson’s and Alzheimer’s.

Congratulations to Anne Brown on her NSF CAREER award!

Anne M. Brown receives NSF CAREER award to use computational modeling to study amyloid interactions With the five-year, $800,000 National Science Foundation Faculty Early Career Development Award, Brown will use her molecular dynamics simulation expertise to shed more light on the differences between amyloids that harm and those that don’t.

Congratulations to the Santos lab on their recent NIH grant!

Virginia Tech drug researcher receives $2.2 million NIH grant to further develop ‘fat burning’ molecule Webster Santos, a professor of chemistry in the College of Science, has received a $2.2 million grant from the National Institutes of Health to further his recent research with mitochondrial uncouplers - small "fat burning" molecules that could be used to help treat NASH.

VTCDD's Slade and Verbridge collaborating to crack pancreatic cancer!

Virginia Tech researchers discover how bacteria make pancreatic cancer cells grow and move Pancreatic cancer is the third-leading cause of cancer-related death in the United States. Several characteristics make the disease difficult to treat, including its ability to suppress the immune system and its complex location and structure, which complicate surgery and chemotherapy delivery.

Great article on Dr. Mevers' recent NIH grant!

Chemistry’s Emily Mevers utilizes marine egg masses for medical innovations Mevers, of the Department of Chemistry, received a five-year, $1.9 million grant from the National Institutes of Health that aims to leverage the microbiomes of marine egg masses for the development of next-generation antibiotics to treat emerging pathogens.

Congratulations to new CeZAP director and VTCDD member Kylene Kehn-Hall!

Virologist Kylene Kehn-Hall to direct the Center for Emerging, Zoonotic, and Arthropod-borne Pathogens Kehn-Hall, professor of virology from the Virginia-Maryland College of Veterinary Medicine, conducts research focused on understanding the mechanism of viral pathogenesis and developing antivirals for vector-borne and zoonotic diseases.

Exciting new discovery from VTCDD's Webster Santos in the field of kidney fibrosis!

Webster Santos brings molecule inhibitor discovery in chronic kidney disease closer to drug treatment Chronic kidney disease almost certainly ends in fatal renal failure. The costs are enormous, not only in lives, but also to the economy. According to 2017 estimates, chronic kidney disease cost the U.S. economy $84 billion, and end-stage renal disease treatment added another $36 billion.

VTCDD's own Lijuan Yuan at the forefront of exciting new vaccine research!

Virginia Tech researcher to test vaccine for norovirus Lijuan Yuan, professor of virology and immunology at the Virginia-Maryland College of Veterinary Medicine at Virginia Tech, will evaluate a potential live oral vaccine for norovirus, the No. 1 cause of foodborne illness.

VTCDD member John Matson's faculty inventor spotlight!

John Matson Matson, develops small molecules and nanomaterials with applications in medicine, biology and sustainability.

VTCDD director Paul Carlier is featured in Link+License+Launch's recent inventor spotlight!

Paul Carlier Fueled by a passion for science, Carlier is a medicinal chemist who harnesses the power of synthetic chemistry to advance biology, medicine, and public health.